Nutrition Coaching for Pancreatic Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if remote nutrition coaching can assist people with pancreatic cancer during chemotherapy. Participants in the experimental group will receive dietary advice every two weeks to address nutrition concerns and follow an anti-inflammatory diet. The trial seeks individuals with newly diagnosed pancreatic tumors who are about to begin chemotherapy. Candidates who can eat by mouth and have no major psychiatric or neurological issues may be suitable. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance nutritional support for future patients.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this remote nutrition coaching and monitoring intervention is safe?
Studies have shown that remote nutrition coaching is generally safe and well-liked by patients. In earlier research, most participants stayed with the program, with 79% tracking their food intake most days and meeting with a dietitian regularly. This suggests that the program is user-friendly and harmless. No serious side effects were reported in these studies. The program focuses on helping patients manage their diet better, which is not known to cause any negative side effects.12345
Why are researchers excited about this trial?
Researchers are excited about the Nutrition Coaching and Monitoring Intervention for pancreatic cancer because it offers a personalized and proactive approach to patient care. Unlike traditional treatments that focus primarily on medical interventions, this method emphasizes dietary coaching tailored to each patient's needs, aiming to optimize treatment response through nutrition. By focusing on anti-inflammatory diets and setting specific, achievable goals, this approach could improve patients' overall well-being and enhance the effectiveness of conventional treatments. This represents a shift towards integrating lifestyle changes with medical care, potentially leading to better health outcomes for pancreatic cancer patients.
What evidence suggests that this remote nutrition coaching and monitoring intervention is effective for pancreatic cancer?
Research shows that remote nutrition coaching, which participants in this trial may receive, can improve diet and treatment response in people with pancreatic cancer. Studies have found that patients receiving this support often adhere better to anti-inflammatory diets, potentially reducing inflammation and enhancing overall health. Early results suggest that this approach is practical and acceptable to patients, as they are willing to try it and find it easy to manage. While strong evidence on its direct effectiveness for pancreatic cancer is still being gathered, promising results in related areas suggest potential benefits.12346
Who Is on the Research Team?
Sylvia Crowder, PhD
Principal Investigator
Moffitt Cancer Center
Pamela Hodul, MD
Principal Investigator
Moffitt Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 with newly diagnosed, non-metastatic pancreatic cancer who are about to start chemotherapy and can eat by mouth. They must be able to understand English and give verbal consent. People with serious mental disorders or those on tube feeding, pregnant women, or patients with bowel obstruction risks cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a remote nutrition coaching and monitoring intervention during the 12 weeks of active chemotherapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Remote Nutrition Coaching and Monitoring Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor